Hanmi Science Co., Ltd. (KRX:008930)
South Korea · Delayed Price · Currency is KRW 44,500
+2,400 (5.70%)
Aug 28, 2026, 3:30 PM KST
Hanmi Science Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,013,260 | 2,454,622 | 1,994,169 | 2,664,917 | 2,206,472 | 3,646,182 | |
Market Cap Growth | 8.54% | 23.09% | -25.17% | 20.78% | -39.48% | -27.37% |
Enterprise Value | 3,098,295 | 2,583,224 | 2,164,309 | 2,827,584 | 2,254,564 | 3,688,884 |
Last Close Price | 44500.00 | 35966.80 | 29219.92 | 38506.40 | 31709.16 | 51632.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 19.98 | 20.74 | 33.56 | 23.15 | 31.88 | 84.91 |
PS Ratio | 2.14 | 1.81 | 1.55 | 2.14 | 2.11 | 3.84 |
PB Ratio | 2.84 | 2.56 | 2.35 | 3.35 | 3.04 | 5.28 |
P/TBV Ratio | 2.88 | 2.59 | 2.54 | 3.70 | 3.13 | 5.34 |
P/FCF Ratio | 108.19 | 85.44 | 27.26 | 94.41 | 1074.16 | 307.07 |
P/OCF Ratio | 64.27 | 51.51 | 24.03 | 75.80 | 233.45 | 266.34 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.20 | 1.90 | 1.69 | 2.27 | 2.15 | 3.88 |
EV/EBITDA Ratio | 16.11 | 38.88 | 45.40 | 43.01 | 67.12 | 108.47 |
EV/EBIT Ratio | 16.93 | 45.35 | 57.02 | 49.60 | 80.20 | 128.30 |
EV/FCF Ratio | 111.25 | 89.91 | 29.59 | 100.17 | 1097.57 | 310.67 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.17 | 0.22 | 0.26 | 0.27 | 0.28 | 0.08 |
Debt / EBITDA Ratio | 2.41 | 3.23 | 4.56 | 3.25 | 6.01 | 1.66 |
Debt / FCF Ratio | 6.61 | 7.47 | 2.97 | 7.57 | 98.34 | 4.76 |
Net Debt / Equity Ratio | 0.08 | 0.09 | 0.15 | 0.23 | 0.25 | 0.06 |
Net Debt / EBITDA Ratio | 1.11 | 1.30 | 2.69 | 2.73 | 5.37 | 1.17 |
Net Debt / FCF Ratio | 3.05 | 3.01 | 1.75 | 6.35 | 87.87 | 3.36 |
Asset Turnover | 0.97 | 0.96 | 1.00 | 1.07 | 1.02 | 1.01 |
Inventory Turnover | 8.93 | 9.04 | 9.51 | 9.09 | 8.12 | 0.02 |
Quick Ratio | 0.52 | 0.48 | 0.42 | 0.37 | 0.35 | 0.50 |
Current Ratio | 0.90 | 0.80 | 0.72 | 0.71 | 0.71 | 1.01 |
Return on Equity (ROE) | 15.54% | 13.02% | 6.89% | 15.14% | 9.76% | 6.37% |
Return on Assets (ROA) | 2.88% | 2.51% | 1.84% | 3.05% | 1.71% | 1.92% |
Return on Invested Capital (ROIC) | 5.16% | 4.99% | 3.50% | 5.35% | 3.24% | 3.53% |
Return on Capital Employed (ROCE) | 6.00% | 5.70% | 4.30% | 6.80% | 3.70% | 3.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.01% | 4.82% | 2.98% | 4.32% | 3.14% | 1.18% |
FCF Yield | 0.92% | 1.17% | 3.67% | 1.06% | 0.09% | 0.33% |
Payout Ratio | 13.47% | 11.44% | 34.20% | 11.58% | 19.06% | 30.12% |
Buyback Yield / Dilution | -0.21% | -0.11% | 0.41% | 0.79% | 0.18% | 0.02% |